Miramar Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.5M | Sell |
103,550
-2,477
| -2% | -$286K | 2.77% | 20 |
|
|
2025
Q4 | $11.2M | Sell |
106,027
-174
| -0.2% | -$16.3K | 2.44% | 23 |
|
|
2025
Q3 | $8.91M | Buy |
106,201
+19,685
| +23% | +$1.62M | 1.98% | 28 |
|
|
2025
Q2 | $6.85M | Buy |
86,516
+1,029
| +1% | +$81.8K | 1.62% | 28 |
|
|
2025
Q1 | $7.67M | Sell |
85,487
-2,204
| -3% | -$206K | 1.83% | 29 |
|
|
2024
Q4 | $8.72M | Buy |
87,691
+10,330
| +13% | +$1.06M | 2.08% | 28 |
|
|
2024
Q3 | $8.79M | Sell |
77,361
-932
| -1% | -$111K | 2.05% | 29 |
|
|
2024
Q2 | $9.69M | Buy |
78,293
+844
| +1% | +$109K | 2.42% | 26 |
|
|
2024
Q1 | $10.1M | Sell |
77,449
-1,410
| -2% | -$174K | 2.55% | 24 |
|
|
2023
Q4 | $8.6M | Sell |
78,859
-2,869
| -4% | -$298K | 2.24% | 26 |
|
|
2023
Q3 | $8.41M | Sell |
81,728
-3,109
| -4% | -$335K | 2.29% | 25 |
|
|
2023
Q2 | $9.79M | Sell |
84,837
-1,067
| -1% | -$121K | 2.48% | 25 |
|
|
2023
Q1 | $9.14M | Sell |
85,904
-26,940
| -24% | -$2.91M | 2.35% | 23 |
|
|
2022
Q4 | $12.5M | Buy |
112,844
+172
| +0.2% | +$17.6K | 3.28% | 10 |
|
|
2022
Q3 | $11.4M | Sell |
112,672
-20,690
| -16% | -$1.85M | 3.15% | 14 |
|
|
2022
Q2 | $12.2M | Buy |
133,362
+9,125
| +7% | +$809K | 3.44% | 7 |
|
|
2022
Q1 | $10.2M | Buy |
124,237
+14,549
| +13% | +$1.15M | 2.8% | 14 |
|
|
2021
Q4 | $8.41M | Buy |
109,688
+10,480
| +11% | +$835K | 2.85% | 17 |
|
|
2021
Q3 | $7.45M | Buy |
99,208
+5,845
| +6% | +$445K | 2.97% | 20 |
|
|
2021
Q2 | $7.06M | Sell |
93,363
-2,728
| -3% | -$203K | 2.85% | 19 |
|
|
2021
Q1 | $7.07M | Buy |
96,091
+13,132
| +16% | +$969K | 3.16% | 18 |
|
|
2020
Q4 | $5.94M | Buy |
82,959
+20,410
| +33% | +$1.56M | 2.65% | 18 |
|
|
2020
Q3 | $4.8M | Sell |
62,549
-165
| -0.3% | -$12.9K | 2.78% | 23 |
|
|
2020
Q2 | $4.89M | Buy |
62,714
+3,518
| +6% | +$265K | 3.02% | 19 |
|
|
2020
Q1 | $4.35M | Sell |
59,196
-1,463
| -2% | -$115K | 3.96% | 11 |
|
|
2019
Q4 | $5.11M | Sell |
60,659
-384
| -0.6% | -$31.5K | 3.13% | 16 |
|
|
2019
Q3 | $4.92M | Buy |
61,043
+7,454
| +14% | +$597K | 3.32% | 16 |
|
|
2019
Q2 | $4.18M | Buy |
53,589
+716
| +1% | +$54.8K | 2.96% | 16 |
|
|
2019
Q1 | $4.2M | Sell |
52,873
-1,236
| -2% | -$92.4K | 3.21% | 12 |
|
|
2018
Q4 | $4.05M | Buy |
+54,109
| New | +$3.82M | 3.17% | 14 |
|
Other funds holding MRK
VCM
VPM
Miramar Capital's MRK Position: Q1 2026 in Review
Miramar Capital reduced its Merck (MRK) stake by 2.3% in Q1 2026, selling an estimated $286K and leaving 103,550 shares worth $12.5M. The position accounts for 2.77% of the portfolio, ranked #20.
Miramar Capital first reported a position in MRK in Q4 2018 and has held it in 30 quarters since. The position peaked at $12.5M in Q4 2022. 3,776 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Miramar Capital held 103,550 shares of Merck worth $12.5M as of Q1 2026.
- Miramar Capital sold 2,477 Merck shares in Q1 2026, an estimated $286K.
- Merck made up 2.77% of Miramar Capital's portfolio in Q1 2026, its #20 holding.
- Miramar Capital first reported a position in Merck in Q4 2018 and has held it in 30 quarters since.
- Miramar Capital's Merck position peaked at $12.5M in Q4 2022.
- 3,776 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Miramar Capital's 13F filing for Q1 2026, filed 11 May 2026.